✦ LIBER ✦

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

✍ Scribed by Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; David H Miller; Xavier Montalbán; Frederik Barkhof; Ernst-Wilhelm Radü; Lars Bauer; Susanne Dahms; Vivian Lanius; Christoph Pohl; Rupert Sandbrink

Book ID: 117301573
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 183 KB
Volume: 370
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(07)61194-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effect of early treatment with

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

✍ Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 239 KB

Cost-Effectiveness Analysis of Interfero

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis

✍ John P. Caloyeras; Bin Zhang; Cheng Wang; Marianne Eriksson; Sten Fredrikson; Ka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 882 KB

A case study on the effect of neutralizi

A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging

✍ A. W. Chiu; M. Ehrmantraut; N. D. Richert; V. N. Ikonomidou; S. Pellegrini; H. F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views